GlaxoSmithKline Consumer Healthcare Applauds CVS Caremark Corporation's Important Decision To End Sales Of Tobacco Products
PARSIPPANY, N.J., Sept. 4, 2014 /PRNewswire/ -- GlaxoSmithKline (GSK) Consumer Healthcare applauds CVS for its courageous decision to end the sale of tobacco products. This monumental step will go a long way towards improving and protecting public health.
Banning the sale of cigarettes and other harmful tobacco products from its shelf will help CVS encourage current smokers to quit, may prevent potential smokers from starting the deadly habit and may ultimately reduce the prevalence of cigarette smoking, which causes 480,000 deaths annually. CVS has GSK's full support in its quit-smoking initiatives and shares its philosophy of saying "no" to cigarettes and "yes" to quitting.
As leaders in smoking cessation, GSK encourages all smokers who are emboldened by CVS' decision to look to Nicorette gum and NicoDerm CQ patch to help them begin their quit journey. Nicorette and NicoDerm CQ can double a smoker's chances of quitting versus placebo when used as directed. We are committed to helping every smoker achieve a smoke-free life.
About GlaxoSmithKline Consumer Healthcare
GlaxoSmithKline Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare products companies. Its well-known brands include Nicorette® and NicoDerm® CQ, the leading smoking cessation products; alli, the only FDA-OTC weight loss aid; as well as medicine cabinet staples, Aquafresh,® Sensodyne,® Tums® and Breathe Right,® all of which are trademarks owned by and/or licensed to GlaxoSmithKline Group of Companies.
GlaxoSmithKline one of the world's leading research-based pharmaceutical and healthcare companies is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information visit: http://www.GSK.com.
GSK Consumer Healthcare
SOURCE GlaxoSmithKline Consumer Healthcare